Skip to main content

Advertisement

SpringerLink
Log in

Low expressions of ASS1 and OTC in glioblastoma suggest the potential clinical use of recombinant human arginase (rhArg)

  • Letter to the Editor
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Khoury O, Ghazale N, Stone E, El-Sibai M, Frankel AE, Abi-Habib RJ (2015) Human recombinant arginase I (Co)-PEG5000 [HuArgI (Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human glioblastoma cells. J Neurooncol 122(1):75–85. doi:10.1007/s11060-014-1698-5

    Article  CAS  PubMed  Google Scholar 

  2. Lam TL, Wong GK, Chong HC, Cheng PN, Choi SC, Chow TL, Kwok SY, Poon RT, Wheatley DN, Lo WH, Leung YC (2009) Recombinant human arginase inhibits proliferation of human hepatocellular carcinoma by inducing cell cycle arrest. Cancer Lett 277(1):91–100. doi:10.1016/j.canlet.2008.11.031

    Article  CAS  PubMed  Google Scholar 

  3. Fiedler T, Strauss M, Hering S, Redanz U, William D, Rosche Y, Classen CF, Kreikemeyer B, Linnebacher M, Maletzki C (2015) Arginine deprivation by arginine deiminase of Streptococcus pyogenes controls primary glioblastoma growth in vitro and in vivo. Cancer Biol Ther 16(7):1047–1055. doi:10.1080/15384047.2015.1026478

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

We would like to acknowledge Dr. Aden Ka Yin Chan and Prof. Ho Keung Ng for providing us GBM patients samples (Department of Anatomical and Cellular Pathology, The Chinese University of Hong Kong), and also Dr. Kin Pong U and Dr. Paul Ning Man Cheng (BCT International Ltd., Hong Kong) for providing us the compound, PEG-BCT-100.

Author information

Authors and Affiliations

  1. Faculty of Medicine, Department of Clinical Oncology, The Chinese University of Hong Kong, Hong Kong SAR, Hong Kong

    Chi Tung Choy, Chi Hang Wong & Herbert Ho Fung Loong

Authors
  1. Chi Tung Choy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chi Hang Wong
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Herbert Ho Fung Loong
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Chi Hang Wong or Herbert Ho Fung Loong.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Choy, C.T., Wong, C.H. & Loong, H.H.F. Low expressions of ASS1 and OTC in glioblastoma suggest the potential clinical use of recombinant human arginase (rhArg). J Neurooncol 129, 579–581 (2016). https://doi.org/10.1007/s11060-016-2209-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-016-2209-7

Keywords

Search

Navigation